Altimmune, Inc. (NASDAQ:ALT) Given Consensus Rating of “Buy” by Brokerages
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. […]
Altimmune, Inc. (NASDAQ:ALT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. […]
